A proteomic approach for unraveling the oncogenic H-Ras protein networks in NIH/3T3 mouse embryonic fibroblast cells

Jung Wook Park1, Seyoon Kim, Kook Jin Lim

  • 1Department of Biochemistry, College of Science, Yonsei University, Seoul, Korea.

Proteomics
|January 13, 2006
PubMed

Insights

This study identifies 64 proteins affected by oncogenic H-Ras in mouse cells, revealing key players in cancer networks. These findings aid in understanding the complex protein interactions driven by H-Ras mutations.

Area of Science:

  • Cell Biology
  • Molecular Oncology
  • Proteomics

Background:

  • Oncogenic H-Ras mutations are critical drivers of various cancers.
  • Understanding the H-Ras protein network is essential for targeted cancer therapies.

Purpose of the Study:

  • To identify and catalogue proteome-wide changes induced by oncogenic H-Ras (G12V and G12R) in NIH/3T3 cells.
  • To elucidate the direct and indirect protein network influenced by oncogenic H-Ras.

Main Methods:

  • Established stable and doxycycline-inducible NIH/3T3 cell lines expressing oncogenic H-Ras.
  • Utilized 2-DE, quantitative image analysis, and MALDI-TOF MS for proteome profiling.
  • Confirmed differential protein expression using Western blot analysis.

Main Results:

  • Identified 64 common protein targets regulated by oncogenic H-Ras across both expression systems.
  • 36 proteins were up-regulated, and 28 were down-regulated.
  • Comparative proteomic analysis provided interpretable data on H-Ras-mediated protein networks.

Conclusions:

  • Comparative proteomic analysis is a powerful approach to dissecting oncogenic signaling pathways.
  • This study provides a foundational proteome catalogue for understanding H-Ras-driven oncogenesis.
  • The identified proteins represent potential therapeutic targets for H-Ras-related cancers.

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...